Home › Companies › Neurogene Inc. › 2025-2026

Neurogene Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Neurogene Inc.’s Form 8-K, filed June 4, 2026 (Item 5.07 on EDGAR). Page generated October 18, 2026.

  • 7Reported items
  • 131Asset managers
  • 838Fund votes
  • June 3, 2026Meeting date

Results at a glance

Meeting of June 3, 2026: 4 items on Neurogene Inc.’s Form 8-K, filed June 4, 2026: 4 without a stated outcome.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2024-2025 2025-2026

Explore Neurogene Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Neurogene Inc.

These tallies are Neurogene Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 4, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Neurogene Inc. — official shareholder meeting results, meeting held June 3, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Robert Baffi 9,540,734---- 548,7361,297,937 95%Not verified—
Elect Director: Rohan Palekar 10,058,331---- 31,1391,293,937 99.6%Not verified—
2. Approval on an advisory (non-binding) basis of the compensation of the Company's named executive officers 9,991,44536,39461,631 --1,297,937 99.6%Not verified—
3. Ratification on an advisory (non-binding) basis of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026 9,345,9251,939,039102,443 ---- 83%Not verified—

Source: Neurogene Inc., Form 8-K, filed with the SEC on June 4, 2026 — read the filing on EDGAR.

How asset managers voted at the Neurogene Inc. 2025-2026 meeting

Each item below shows how the 131 asset managers that disclosed a Neurogene Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Neurogene Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Director: Robert Baffi

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 9,540,734WITHHELD: 548,736
Details: description as filed, official tally, votes by 40 asset managers

Description as filed by funds: Election of Class III Directors for terms expiring in 2029: Robert Baffi, Ph.D.

Neurogene Inc.’s own tally for this item (“Elect Director: Robert Baffi”): 9,540,734 for, 548,736 withheld, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 40 asset managers below reported 985,429 for, 58,648 withheld, 3,130 abstained.

FOR
FOR: 985,429ABSTAIN: 3,130WITHHOLD: 58,648
Largest asset managers voting on “Election of Class III Directors for terms expiring in 2029: Robert Baffi, Ph.D.” at Neurogene Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity420,1810 00For
BlackRock216,3230 00For
Vanguard210,8820 0106For
Charles Schwab30,0580 00For
State Street26,3730 025For
TIAA19,9430 00For
JPMorgan17,0840 00For
ETFis Series Trust I00 012,416Withhold
Lincoln Financial10,7540 00For
ALPS ETF Trust00 010,519Withhold
Equitable1,8420 07,640Mixed
Dimensional00 08,979Withhold
Brighthouse2,7850 04,197Mixed
SEI5,7180 00For
Global X5,2830 00For
Bridge Builder Trust4,6570 00For
Pacific Life4,4680 00For
American Century00 04,383Withhold
John Hancock00 3,1300Abstain
Goldman Sachs2,3510 00For
ProShares00 02,288Withhold
BRIDGEWAY FUNDS INC00 01,937Withhold
Franklin Templeton1,8400 00For
DWS00 01,584Withhold
T. Rowe Price1,4070 00For

Showing the 25 largest of 40 asset managers. See all 40 in the interactive database.

2. Elect Director: Rohan Palekar

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%
FOR: 10,058,331WITHHELD: 31,139
Details: description as filed, official tally, votes by 40 asset managers

Description as filed by funds: Election of Class III Directors for terms expiring in 2029: Rohan Palekar

Neurogene Inc.’s own tally for this item (“Elect Director: Rohan Palekar”): 10,058,331 for, 31,139 withheld, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.6% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 40 asset managers below reported 1,037,979 for, 9,229 withheld.

FOR
FOR: 1,037,979WITHHOLD: 9,229
Largest asset managers voting on “Election of Class III Directors for terms expiring in 2029: Rohan Palekar” at Neurogene Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity420,1810 00For
BlackRock216,3230 00For
Vanguard210,7650 0223For
Charles Schwab30,0580 00For
State Street26,3720 026For
TIAA19,9430 00For
JPMorgan17,0840 00For
ETFis Series Trust I12,4160 00For
Lincoln Financial10,7540 00For
ALPS ETF Trust10,5190 00For
Equitable9,4820 00For
Dimensional00 08,979Withhold
Brighthouse6,9820 00For
SEI5,7180 00For
Global X5,2830 00For
Bridge Builder Trust4,6570 00For
Pacific Life4,4680 00For
American Century4,3830 00For
John Hancock3,1300 00For
Goldman Sachs2,3510 00For
ProShares2,2880 00For
BRIDGEWAY FUNDS INC1,9370 00For
Franklin Templeton1,8400 00For
DWS1,5840 00For
T. Rowe Price1,4070 00For

Showing the 25 largest of 40 asset managers. See all 40 in the interactive database.

3. 2. Approval on an advisory (non-binding) basis of the compensation of the Company's named executive officers

Outcome not verifiedFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Not verified

Combines 7 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%
FOR: 9,991,445AGAINST: 36,394
Details: description as filed, official tally, votes by 115 asset managers

Description as filed by funds: To approve on an advisory (non- binding) basis the compensation of the Company's named executive officers.

Neurogene Inc.’s own tally for this item (“2. Approval on an advisory (non-binding) basis of the compensation of the Company's named executive officers”): 9,991,445 for, 36,394 against, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 40 asset managers voting on “To approve on an advisory (non- binding) basis the compensation of the Company's named executive officers.” at Neurogene Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity420,1810 00For
BlackRock216,3230 00For
Vanguard210,9880 00For
Charles Schwab30,0580 00For
State Street26,38513 00For
TIAA19,9430 00For
JPMorgan17,0840 00For
ETFis Series Trust I12,4160 00For
Lincoln Financial10,7540 00For
ALPS ETF Trust10,5190 00For
Equitable9,4820 00For
Dimensional8,9790 00For
Brighthouse6,9820 00For
SEI5,7180 00For
Global X5,2830 00For
Bridge Builder Trust4,6570 00For
Pacific Life4,4680 00For
American Century04,383 00Against
John Hancock3,1300 00For
Goldman Sachs2,3510 00For
ProShares2,2880 00For
BRIDGEWAY FUNDS INC01,937 00Against
Franklin Templeton1,8400 00For
DWS1,5840 00For
T. Rowe Price1,4070 00For

Fund voting reports, all 40 managers: 1,040,864 for, 6,343 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 88 asset managers voting on “To approve on an advisory (non- binding) basis the compensation of the Company's named executive officers.” at Neurogene Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Samsara BioCapital, LLC1,717,1270 00For
Redmile Group, LLC01,446,634 00Against
RTW INVESTMENTS, LP1,362,4560 00For
EcoR1 Capital, LLC1,271,3420 00For
GREAT POINT PARTNERS LLC1,000,0000 00For
Trails Edge Capital Partners, LP402,5350 00For
BlackRock298,7436,770 00For
Casdin Capital, LLC265,1380 00For
GEODE CAPITAL MANAGEMENT, LLC251,3030 00For
Fidelity217,3810 00For
State Street163,518160 00For
BLAIR WILLIAM & CO/IL118,7050 00For
Rock Springs Capital Management LP104,3390 00For
Citadel88,5120 00For
Northern Trust67,7480 00For
Woodline Partners LP63,9950 00For
DAFNA Capital Management LLC56,6350 00For
DRIEHAUS CAPITAL MANAGEMENT LLC32,7650 00For
Nuveen23,9100 00For
Vanguard22,0280 00For
MELLON INVESTMENTS Corp19,3880 00For
PNC BANK, NATIONAL ASSOCIATION15,3620 00For
Goldman Sachs10,9660 00For
AllianceBernstein10,5700 00For
JPMorgan8,6960 00For

Institutional-manager reports, all 88 managers: 7,640,855 for, 1,467,883 against, 8 not voted, 1,433 1 year. Showing the 25 largest; see all in the interactive database.

4. To hold a non-binding advisory vote on whether future non-binding advisory votes on the compensation paid by the…

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

100% Fund and manager reports combined; may count the same shares twice · no official result

1 YEAR
Details: description as filed, votes by 100 asset managers

Description as filed by funds: To hold a non-binding advisory vote on whether future non-binding advisory votes on the compensation paid by the company to its named executive officers should be held every one, two or three years.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 36 asset managers voting on “To hold a non-binding advisory vote on whether future non-binding advisory votes on the compensation paid by t” at Neurogene Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity00 00--
Vanguard00 00--
Charles Schwab00 00--
State Street00 00--
TIAA00 00--
JPMorgan00 00--
ETFis Series Trust I00 00--
Lincoln Financial00 00--
ALPS ETF Trust00 00--
Equitable00 00--
Dimensional00 00--
Brighthouse6,1960 00For
SEI00 00--
Global X00 00--
Pacific Life00 00--
American Century00 00--
Goldman Sachs00 00--
ProShares00 00--
BRIDGEWAY FUNDS INC00 00--
Franklin Templeton00 00--
DWS00 00--
T. Rowe Price00 00--
Victory Capital00 00--
AIG/SunAmerica00 00--
Calvert00 00--

Fund voting reports, all 36 managers: 6,196 for, 806,929 1 year, 8,979 3 year, 3 unknown. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 78 asset managers voting on “To hold a non-binding advisory vote on whether future non-binding advisory votes on the compensation paid by t” at Neurogene Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Redmile Group, LLC00 00--
RTW INVESTMENTS, LP00 00--
Trails Edge Capital Partners, LP402,5350 00For
ArrowMark Colorado Holdings LLC00 00--
Casdin Capital, LLC00 00--
GEODE CAPITAL MANAGEMENT, LLC00 00--
Fidelity00 00--
State Street00 00--
BLAIR WILLIAM & CO/IL00 00--
Rock Springs Capital Management LP00 00--
Citadel00 00--
JENNISON ASSOCIATES LLC00 00--
Woodline Partners LP00 00--
DAFNA Capital Management LLC00 00--
Raiffeisen Bank International AG00 00--
DRIEHAUS CAPITAL MANAGEMENT LLC00 00--
Charles Schwab00 00--
BALYASNY ASSET MANAGEMENT L.P.00 00--
Nuveen00 00--
Vanguard00 00--
MELLON INVESTMENTS Corp00 00--
Goldman Sachs00 00--
AllianceBernstein00 00--
JPMorgan00 00--
Mitsubishi UFJ Asset Management Co., Ltd.00 00--

Institutional-manager reports, all 78 managers: 403,968 for, 4,867,306 1 year. Showing the 25 largest; see all in the interactive database.

5. To hold a non-binding advisory vote on whether future non-binding advisory votes on the executive compensation paid by…

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

— Fund and manager reports combined; may count the same shares twice · no official result

1 YEAR
Details: description as filed, votes by 27 asset managers

Description as filed by funds: To hold a non-binding advisory vote on whether future non-binding advisory votes on the executive compensation paid by the company to its named executive officers should be held every one, two, or three years.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 4 asset managers voting on “To hold a non-binding advisory vote on whether future non-binding advisory votes on the executive compensation” at Neurogene Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock00 00--
Bridge Builder Trust00 00--
John Hancock00 00--
WILSHIRE MUTUAL FUNDS INC00 00--

Fund voting reports, all 4 managers: 225,100 1 year.

Institutional-manager reports: 23 asset managers voting on “To hold a non-binding advisory vote on whether future non-binding advisory votes on the executive compensation” at Neurogene Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
GREAT POINT PARTNERS LLC00 00--
BlackRock00 00--
Northern Trust00 00--
PNC BANK, NATIONAL ASSOCIATION00 00--
D.A. DAVIDSON & CO.00 00--
MERCER GLOBAL ADVISORS INC /ADV00 00--
MML INVESTORS SERVICES, LLC00 00--
WELLS FARGO BANK N A00 00--
SmartHarvest Portfolios, LLC00 00--
Savant Capital, LLC00 00--
NORDEN GROUP LLC00 00--
Pathstone Holdings, LLC00 00--
Bleakley Financial Group, LLC00 00--
Frec Advisers LLC00 00--
FIRST AMERICAN TRUST, FSB00 00--
Sanctuary Advisors, LLC00 00--
GAMMA Investing LLC00 00--
Perigon Wealth Management, LLC00 00--
ENVESTNET ASSET MANAGEMENT INC00 00--
WELLS FARGO CLEARING SERVICES, LLC00 00--
National Bank Financial Inc.00 00Not Voted
BOYD WATTERSON ASSET MANAGEMENT LLC/OH00 00--
Alteri Wealth LLC00 00--

Institutional-manager reports, all 23 managers: 8 not voted, 1,393,977 1 year, 17 3 year.

6. To hold an advisory (non-binding) vote on whether future non-binding advisory votes on the compensation paid by the…

No official matchSECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 2 asset managers

Description as filed by funds: To hold an advisory (non-binding) vote on whether future non-binding advisory votes on the compensation paid by the Company to its named executive officers should be held every one, two or three years

The 2 asset managers below reported 1,271,342 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 1,271,342
Largest asset managers voting on “To hold an advisory (non-binding) vote on whether future non-binding advisory votes on the compensation paid b” at Neurogene Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
EcoR1 Capital, LLC1,271,3420 00For
IPConcept (Luxemburg) S.A.00 00--

7. 3. Ratification on an advisory (non-binding) basis of the appointment of Deloitte & Touche LLP as the Company's…

Outcome not verifiedFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Not verified

83% Majority: yes · of votes cast

FOR 83%AGAINST
FOR: 9,345,925AGAINST: 1,939,039
Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: To ratify on an advisory (non- binding) basis the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.

Neurogene Inc.’s own tally for this item (“3. Ratification on an advisory (non-binding) basis of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026”): 9,345,925 for, 1,939,039 against, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 83% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 40 asset managers voting on “To ratify on an advisory (non- binding) basis the appointment of Deloitte & Touche LLP as the Company's indepe” at Neurogene Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity420,1810 00For
BlackRock216,3230 00For
Vanguard210,881107 00For
Charles Schwab30,0580 00For
State Street26,3980 00For
TIAA19,9430 00For
JPMorgan17,0840 00For
ETFis Series Trust I12,4160 00For
Lincoln Financial10,7540 00For
ALPS ETF Trust10,5190 00For
Equitable9,4820 00For
Dimensional8,9790 00For
Brighthouse6,9820 00For
SEI05,718 00Against
Global X05,283 00Against
Bridge Builder Trust4,6570 00For
Pacific Life4,4680 00For
American Century4,3830 00For
John Hancock3,1300 00For
Goldman Sachs2,3510 00For
ProShares2,2880 00For
BRIDGEWAY FUNDS INC1,9370 00For
Franklin Templeton01,840 00Against
DWS1,5840 00For
T. Rowe Price1,4070 00For

Fund voting reports, all 40 managers: 1,031,418 for, 15,789 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 17 asset managers voting on “To ratify on an advisory (non- binding) basis the appointment of Deloitte & Touche LLP as the Company's indepe” at Neurogene Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ArrowMark Colorado Holdings LLC0354,220 00Against
JENNISON ASSOCIATES LLC64,0380 00For
Raiffeisen Bank International AG00 43,0000Abstain
Charles Schwab30,0580 00For
BALYASNY ASSET MANAGEMENT L.P.029,328 00Against
SEI06,244 00Against
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM04,907 00Against
NEW YORK STATE COMMON RETIREMENT FUND04,200 00Against
Prudential/PGIM1,6000 00For
BANK OF AMERICA NA01,408 00Against
LOS ANGELES CAPITAL MANAGEMENT LLC335990 00Mixed
Neuberger Berman0879 00Against
Russell Investments0856 00Against
WASHINGTON STATE INVESTMENT BOARD0789 00Against
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM6040 00For
YOUSIF CAPITAL MANAGEMENT, LLC0100 00Against
NISA INVESTMENT ADVISORS, LLC630 00For

Institutional-manager reports, all 17 managers: 96,698 for, 403,921 against, 43,000 abstained.

Largest Neurogene Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 15,801,901 shares outstanding at the time of that meeting.

Fund voting reports: top Neurogene Inc. shareholders by shares voted on “To approve on an advisory (non- binding) basis the compensation of the Company's named…”, 2025-2026
#Asset manager % of shares outstanding
1Fidelity 2.66%
2BlackRock 1.37%
3Vanguard 1.34%
4Charles Schwab 0.19%
5State Street 0.17%
6TIAA 0.13%
7JPMorgan 0.11%
8ETFis Series Trust I 0.08%
9Lincoln Financial 0.07%
10ALPS ETF Trust 0.07%
Institutional-manager reports: top Neurogene Inc. shareholders by shares voted on “To approve on an advisory (non- binding) basis the compensation of the Company's named…”, 2025-2026
#Asset manager % of shares outstanding
1Samsara BioCapital, LLC 10.87%
2Redmile Group, LLC 9.15%
3RTW INVESTMENTS, LP 8.62%
4EcoR1 Capital, LLC 8.05%
5GREAT POINT PARTNERS LLC 6.33%
6Trails Edge Capital Partners, LP 2.55%
7BlackRock 1.93%
8Casdin Capital, LLC 1.68%
9GEODE CAPITAL MANAGEMENT, LLC 1.59%
10Fidelity 1.38%

Reported Neurogene Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

Neurogene Inc. holdings and ownership disclosed for the 2025-2026 proxy season
Holder % outstanding Disclosure
Samsara BioCapital, L.P. 10.95% DEF14A
Entities affiliated with Baker Brothers Investments 10.28% DEF14A
Entities affiliated with EcoR1 Capital Fund, L.P. 10.09% DEF14A
Entities affiliated with RTW Investments, LP 10.03% DEF14A
Entities affiliated with Redmile Group, LLC 9.95% DEF14A
Redmile Group, LLC 9.95% 13G
Rachel McMinn 9.02% DEF14A
Entities affiliated with Casdin Capital, LLC 8.20% DEF14A
Entities affiliated with BlackRock Capital Management, Inc. 6.40% DEF14A
Entities affiliated with Trails Edge Capital Partners, LP 4.97% DEF14A

Percentages above are of 15,801,901 shares outstanding, as reported by Neurogene Inc. on its Form 10-Q dated May 8, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Neurogene Inc.’s 10-Q dated May 8, 2026. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.

At Neurogene Inc.'s shareholder meeting held June 3, 2026, in the 2025-2026 proxy season, 131 asset managers reported how they voted in their SEC Form N-PX filings, covering 838 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve on an advisory (non- binding) basis the compensation of the Company's named… — FOR was 99.6% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Neurogene Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 4, 2026.

Neurogene Inc. proxy season coverage: 2024-2025 · 2025-2026 (this page).

Download data (CSV): ballot items · votes by manager · column guide.